Reneuron Limited
Research and experimental development on biotechnology · Weybridge
ActiveUnited KingdomIncorporated 1997Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
03375897- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1997-05-23
- Jurisdiction
- —
- Registered office
- 1BELGRAVE HOUSE, 39-43 MONUMENT HILL, WEYBRIDGE, SURREY, KT13 8RN, ENGLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
15 matched grantsCardiff University and ReNeuron LimitedInnovate UK · Knowledge Transfer Partnership · 2019-07-01 – 2021-06-30 · with 1 other participant
Cardiff University and ReNeuron Limited
Innovate UK · Knowledge Transfer Partnership · 2019-07-01 – 2021-06-30 · with 1 other participant
ReNeuron Limited—
Single Cell Transcriptome Profiling for Advanced Cell Therapy Manufacturing Process MonitoringLeadInnovate UK · Feasibility Studies · 2018-04-01 – 2019-03-31 · with 1 other participant£44,998awarded
Single Cell Transcriptome Profiling for Advanced Cell Therapy Manufacturing Process MonitoringLead
Innovate UK · Feasibility Studies · 2018-04-01 – 2019-03-31 · with 1 other participant
£44,998
awarded
ReNeuron Limitedlead£44,998
National Instiute for Biological standards and controls£24,998
Single Cell Transcriptome Profiling for Advanced Cell Therapy Manufacturing Process MonitoringISCF · Feasibility Studies · 2018-03-31 – 2019-03-31 · with 1 other participant£69,996whole project
Single Cell Transcriptome Profiling for Advanced Cell Therapy Manufacturing Process Monitoring
ISCF · Feasibility Studies · 2018-03-31 – 2019-03-31 · with 1 other participant
£69,996
whole project
Reneuron LimitedleadNational Instiute For Biological Standards And Controls
Single Cell Transcriptome Profiling for Advanced Cell Therapy Manufacturing Process MonitoringLeadISCF · Feasibility Studies · 2018-03-31 – 2019-03-31 · with 1 other participant£69,996whole project
Single Cell Transcriptome Profiling for Advanced Cell Therapy Manufacturing Process MonitoringLead
ISCF · Feasibility Studies · 2018-03-31 – 2019-03-31 · with 1 other participant
£69,996
whole project
Reneuron LimitedleadNational Instiute For Biological Standards And Controls
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightISCF · Collaborative R&D · 2018-02-01 – 2020-04-29 · with 3 other participants£1,530,973whole project
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sight
ISCF · Collaborative R&D · 2018-02-01 – 2020-04-29 · with 3 other participants
£1,530,973
whole project
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightLeadISCF · Collaborative R&D · 2018-02-01 – 2020-04-29 · with 3 other participants£1,530,973whole project
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightLead
ISCF · Collaborative R&D · 2018-02-01 – 2020-04-29 · with 3 other participants
£1,530,973
whole project
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightLeadInnovate UK · Collaborative R&D · 2018-02-01 – 2020-04-30 · with 3 other participants£290,056awarded
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightLead
Innovate UK · Collaborative R&D · 2018-02-01 – 2020-04-30 · with 3 other participants
£290,056
awarded
Cell Therapy Catapult Limited£300,140
ReNeuron Limitedlead£290,056
Process development for recovery and purification of exosomes for regenerative therapyCOVID · Studentship · 2017-09-30 – 2022-03-24 · with 2 other participants£0whole project
Process development for recovery and purification of exosomes for regenerative therapy
COVID · Studentship · 2017-09-30 – 2022-03-24 · with 2 other participants
£0
whole project
Cell2Sell: commercial scale next generation platform for allogeneic stem cell productionLeadInnovate UK · Collaborative R&D · 2017-05-01 – 2018-10-31 · with 1 other participant£750,000awarded
Cell2Sell: commercial scale next generation platform for allogeneic stem cell productionLead
Innovate UK · Collaborative R&D · 2017-05-01 – 2018-10-31 · with 1 other participant
£750,000
awarded
ReNeuron Limitedlead£750,000
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd
Stem cell-derived exosomes for regenerative medicineLeadInnovate UK · Collaborative R&D · 2016-05-01 – 2019-07-31 · with 2 other participants£920,929awarded
Stem cell-derived exosomes for regenerative medicineLead
Innovate UK · Collaborative R&D · 2016-05-01 – 2019-07-31 · with 2 other participants
£920,929
awarded
Novel Engineered Living Neural Tissue, for Peripheral Nerve RepairInnovate UK · Collaborative R&D · 2014-02-01 – 2015-12-31 · with 2 other participants£69,279awarded
Novel Engineered Living Neural Tissue, for Peripheral Nerve Repair
Innovate UK · Collaborative R&D · 2014-02-01 – 2015-12-31 · with 2 other participants
£69,279
awarded
ReNeuron Limited£69,279
A Phase II Simon Two-Stage Efficacy Study of Intracerebral CTX-DP in Patients with Stable Paresis of the Arm Following an Ischaemic StrokeLead
Innovate UK · Collaborative R&D · 2014-01-01 – 2016-12-31
£1,256,563
awarded
Retinal Progenitor Cell Therapy Product for Ocular DiseaseLeadInnovate UK · Collaborative R&D · 2013-06-01 – 2015-05-31 · with 1 other participant£484,516awarded
Retinal Progenitor Cell Therapy Product for Ocular DiseaseLead
Innovate UK · Collaborative R&D · 2013-06-01 – 2015-05-31 · with 1 other participant
£484,516
awarded
ReNeuron Limitedlead£484,516
A Phase I Safety Study of Intramuscular CTX0E03 in Lower Limb Ischaemic PatientsLead
Innovate UK · Collaborative R&D · 2013-06-01 – 2017-02-28
£393,283
awarded